You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 12, 2025

Drug Price Trends for NDC 60505-2526


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 60505-2526

Drug NameNDCPrice/Unit ($)UnitDate
MODAFINIL 100 MG TABLET 60505-2526-01 0.30620 EACH 2025-03-19
MODAFINIL 100 MG TABLET 60505-2526-03 0.30620 EACH 2025-03-19
MODAFINIL 100 MG TABLET 60505-2526-01 0.27795 EACH 2025-02-19
MODAFINIL 100 MG TABLET 60505-2526-03 0.27795 EACH 2025-02-19
MODAFINIL 100 MG TABLET 60505-2526-01 0.24017 EACH 2025-01-22
MODAFINIL 100 MG TABLET 60505-2526-03 0.24017 EACH 2025-01-22
MODAFINIL 100 MG TABLET 60505-2526-01 0.24096 EACH 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 60505-2526

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
MODAFINIL 100MG TAB Golden State Medical Supply, Inc. 60505-2526-03 30 14.36 0.47867 2023-06-16 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 1 of 1 entries

Market Analysis and Price Projections for Modafinil (NDC: 60505-2526)

Introduction to Modafinil

Modafinil, a Schedule IV controlled substance, is widely used to treat conditions such as narcolepsy, obstructive sleep apnea, and shift work disorder. It is known for its psychoactive and euphoric effects, making it a closely monitored medication[1].

Current Market Trends

Global Pharmaceutical Market

The global pharmaceutical market, including the segment for modafinil, is expected to see robust growth. According to industry trends, global pharmaceutical output is forecast to increase by 3% in 2024, 4% in 2025, and 3.6% in 2026. Regions like the Asia Pacific and the Middle East are anticipated to have the largest annual growth rates[3].

US Pharmaceutical Market

In the United States, the pharmaceutical sector is characterized by robust sales and low credit risk. The US pharmaceuticals output is expected to increase by 2.9% in 2024 and 2.5% in 2025, following a significant 17.3% surge in 2023. This growth is driven by an ageing population and increasing demand for medications, including those for chronic conditions and weight loss[3].

Price Trends for Modafinil

Current Pricing

As of December 2024, the prices for modafinil tablets (NDC: 60505-2526) vary slightly depending on the vendor and the dosage.

  • 100 MG Tablet: The price per unit is approximately $0.24 to $0.48, with a total price for a 30-count package ranging from $14.36 to $31.28[5].
  • 200 MG Tablet: The price per unit is around $0.32 to $0.66, with a total price for a 30-count package ranging from $19.68 to $31.28[5].

Historical Price Changes

The prices of prescription drugs, including modafinil, have generally increased over the years, though at varying rates. For instance, the AARP report indicates that retail prices for commonly used drugs have increased faster than the rate of general inflation every year from 2006 until 2020[2].

Generic vs. Branded Prices

Generic versions of modafinil, such as those with the NDC 60505-2526, tend to be more affordable compared to branded versions. The competition in the generics market can significantly reduce prices. For example, the wholesale acquisition cost (WAC) for generic fingolimod, another medication, was reduced by 84% to 97% due to competition[4].

Regulatory Impact on Pricing

Drug Pricing Regulations

The US government has taken steps to reduce pharmaceutical prices, which could impact the pricing of modafinil. Regulations and laws aimed at controlling price hikes, such as the provisions in the new AARP-backed Rx law, may influence future price trends[2][3].

Transparency and Reporting

Efforts to increase transparency in drug pricing, such as the Prescription Drug Price Transparency Program, aim to provide better insights into why drugs are priced as they are and how prices change over time. This transparency can help in managing and predicting price fluctuations[4].

Market Projections

Short-Term Projections

Given the current trends, it is likely that the prices of modafinil will remain relatively stable in the short term, with minor adjustments based on market competition and regulatory changes.

Long-Term Projections

In the long term, the demand for modafinil is expected to remain strong due to the growing need for treatments of sleep disorders and other conditions. However, the prices may be influenced by broader market trends, including the impact of ageing populations and emerging markets. The forecasted growth in the pharmaceutical sector, particularly in regions like the Asia Pacific, could also drive demand and potentially stabilize or reduce prices through increased competition[3].

Key Factors Influencing Price

Demand and Supply

The ageing population and the increasing prevalence of chronic conditions will drive demand for medications like modafinil. This demand, coupled with the supply dynamics influenced by regulatory environments and market competition, will play a crucial role in determining future prices[3].

Regulatory Environment

Government policies and regulations aimed at controlling drug prices will significantly impact the pricing of modafinil. Any changes in these policies could lead to price adjustments[2][3].

Competition

The presence of generic versions and the competition within the pharmaceutical market will continue to influence the pricing of modafinil. Increased competition often leads to lower prices as manufacturers strive to remain competitive[4].

Conclusion

The market for modafinil, as represented by the NDC 60505-2526, is part of a larger pharmaceutical landscape that is experiencing robust growth driven by demographic changes and regulatory factors. While short-term price stability is anticipated, long-term projections suggest that prices could be influenced by broader market trends, regulatory changes, and competition within the generics market.

Key Takeaways

  • Market Growth: The global and US pharmaceutical markets are expected to grow, driven by an ageing population and increasing demand for chronic condition treatments.
  • Price Stability: Short-term prices for modafinil are likely to remain stable with minor adjustments.
  • Regulatory Impact: Government regulations aimed at controlling drug prices could influence future price trends.
  • Competition: Generic competition is a key factor in reducing prices.
  • Demand: Increasing demand due to demographic changes will drive the market for modafinil.

FAQs

  1. What is the current price range for modafinil tablets (NDC: 60505-2526)?

    • The current price range for modafinil 100 MG tablets is approximately $0.24 to $0.48 per unit, and for 200 MG tablets, it is around $0.32 to $0.66 per unit[5].
  2. How do regulatory changes affect the pricing of modafinil?

    • Regulatory changes, such as those aimed at controlling drug price hikes, can significantly impact the pricing of modafinil by imposing penalties on manufacturers for excessive price increases[2][3].
  3. What role does competition play in the pricing of modafinil?

    • Competition, especially from generic versions, can significantly reduce the prices of modafinil by increasing market pressure on manufacturers to lower their prices[4].
  4. How does the ageing population influence the demand for modafinil?

    • The ageing population drives demand for medications like modafinil, which are used to treat chronic conditions and sleep disorders, thereby influencing market dynamics and prices[3].
  5. What are the long-term projections for the pharmaceutical market, including modafinil?

    • Long-term projections indicate robust growth in the pharmaceutical sector, with modafinil prices potentially being influenced by broader market trends, regulatory changes, and competition[3].

Sources

  1. DailyMed: Modafinil tablet - DailyMed.
  2. AARP: AARP Report Finds Top 10 Prescription Drug Price Hikes.
  3. Atradius: Industry Trends Pharmaceuticals September 2024.
  4. Oregon Department of Consumer and Business Services: Prescription Drug Price Transparency Program results and ...
  5. Drug Patent Watch: Pharmaceutical drug prices and trends for modafinil.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.